Vitamin B3 (Niacin) for Cholesterol Management

Research suggests that niacin has been examined as a potential lipid-modulating agent in contexts beyond its traditional role in cholesterol management, including its investigation as part of a broader class of lipid-related drugs studied during the COVID-19 pandemic. The available linked evidence consists of a single 2021 systematic review of randomized controlled trials that evaluated niacin alongside other lipid-modulating agents, focusing primarily on COVID-19 outcomes rather than cholesterol management specifically. Because the study identified here does not directly assess niacin's effectiveness for cholesterol management as its primary outcome, the evidence base represented in this particular collection is limited and does not speak directly to that use case. Readers interested in niacin's well-established but also debated role in managing cholesterol levels, including its effects on HDL, LDL, and triglycerides, should seek out the broader body of clinical literature dedicated to that question, which extends well beyond what is captured here.